Peel Therapeutics is on an expedition to unlock nature’s secrets and overcome life-threatening conditions.
These evolutionary outliers rarely make their way to patients, and we are determined to change that.
We are an evolutionary-inspired, clinical-stage biotech company developing medicines to transform patients’ lives. Peel (the Hebrew word for “elephant”) launched with our focus on cancer-fighting proteins in elephants and we quickly recognized the power of using evolution’s solutions to treat and prevent disease. In addition to developing elephant p53 (EP53) nanoparticles for the treatment of cancer, our team is advancing additional therapies derived from nature’s superpowers to treat cancer and inflammation.
CEO & co-founder
Consultant
Director of operations
Director of preclinical programs
Research associate
Scientific consultant
Stay connected to everything happening at Altitude Lab.
You can trust us with your email. We don't spam.